Ph.D. Kiernan Seth - 10 Feb 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Chief Commercial Officer
Signature
/s/ Kiernan Seth, Ph.D.
Issuer symbol
LXRX
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:09:30 UTC
Previous filing
29 Oct 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +206,670 $0.000000 206,670 10 Feb 2022 Common Stock 206,670 $3.20 Direct F1
transaction LXRX Restricted Stock Units Award $0 +68,890 $0.000000 68,890 10 Feb 2022 Common Stock 68,890 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.